Clinical Trials Logo

Clinical Trial Summary

Recently a low-volume polyethylene glycol containing ascorbic acid (PEG-Asc) formulation has proven as safe and effective as traditional 4-L PEG solutions for colonoscopy preparation. However, currently available aqueous purgative formulations are poorly tolerated. The aim of this study was to compare a split-dose 2-L PEG-Asc and a 1-L PEG-Asc with bisacodyl (10 mg) formulation to determine the quality of bowel cleansing and patient tolerability.


Clinical Trial Description

- Study design A single center, randomized, comparative observer-blinded study was performed from May 2015 to September 2015 at the Department of Gastroenterology and Digestive Endoscopy at Korea University Anam Hospital (Seoul, Korea).

In total, 200 outpatients received lower volume 1-L PEG with ascorbic acid plus bisacodyl (1L-PEG/AB) or low volume 2-L PEG with ascorbic acid (2L-PEG/A) in a 1:1 ratio.

At the time of registration, subjects were randomly allocated to either group. They were randomized by a computer-generated list and were provided with written instructions. All patients provided written informed consent.

- Patients All patients between the ages of 20 and 75 years. Patients were excluded from the analysis if they had known or suspected gastrointestinal obstruction, Ileus, severe heart failure, uncontrolled hypertension (systolic pressure > 170 mmHg, diastolic pressure > 100 mmHg), severe constipation, clinically significant electrolyte abnormalities, any prior bowel resection, or significant gastroparesis.

- Bowel preparation In the 2L-PEG/A group, 1 L of PEG containing ascorbic acid was taken at 8:00 pm on the day before the colonoscopy, followed by an extra 500 mL of water. The second 1-L of PEG containing ascorbic acid was taken 4 h before the colonoscopy examination, with an additional 500 mL of water. Each liter of preparation and the extra 500 mL water had to be consumed within 2 h of the procedure.

The 1L-PEG/AB group received 10 mg bisacodyl at 9:00 pm on the day before the colonoscopy. Four hours before the colonoscopy examination, 1 L of PEG containing ascorbic acid was taken, followed by an additional 1 L of water. The preparation was completed 2 h before the examination. All colonoscopies were performed between 9 am and 1 pm.

- Assessment by endoscopists Colonoscopies were performed by two expert endoscopists who were blinded to the preparation regimen. These two endoscopists worked for more than 5 years at our institution.

Bowel cleansing was scored by the same endoscopist performing the colonoscopy. To assess the cleansing quality of the bowel preparations, the Boston Bowel Preparation Scale (BBPS) and the Aronchick Bowel Preparation Scale (ABPS) were used.

- Assessment of patient tolerability and adverse events Before the colonoscopy procedure, patients completed questionnaires about their symptoms associated with the preparations to assess tolerability. Patients were asked to assess the degree of abdominal fullness, abdominal pain, nausea, vomiting, sleep disturbances, and general discomfort using a 5-point scale (i.e., none, mild, moderate, severe, or very severe).

The palatability of the preparation was graded in 5 categories: very good, good, acceptable, disgusting, and bad.

- Sample size and statistical analysis A sample size of at least 89 patients group was required for each treatment group to detect a difference in treatment success of a 5% type-I error rate and 80% power for a two-tailed χ2 test. Our sample size was based on the results from a pilot study that was conducted in our hospital and included 35 patients in each group. It was estimated that the efficacy for excellent treatment success would be 49% with PEG-2L/A and 30% with PEG-1L/AB. Based on these data, we decided to collect 100 patients per treatment group for study.

Continuous variables were expressed as mean ± standard deviation (SD), and discontinuous variables were expressed as counts and percentages. SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, US) was used for data entry and statistical analyses. For the analyses between the two treatment groups, Students t-test as appropriate was used to compare continuous variables and either the Chi-square or Fisher's exact test were used for categorical data. The p-values < 0.05 were considered statistically significant. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)


Related Conditions & MeSH terms


NCT number NCT02980562
Study type Interventional
Source Korea University Anam Hospital
Contact
Status Completed
Phase Phase 3
Start date May 2015
Completion date December 2015

See also
  Status Clinical Trial Phase
Terminated NCT04555135 - A Clinical Study To Measure The Effect Of Use Of Artificial Intelligence (AI) Enabled Computer Aided Detection (CADe) Assistance Software In Detecting Colon Polyps During Standard Colonoscopy Procedures N/A
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Completed NCT03551379 - A Double Balloon Endoscopic Platform for ESD
Completed NCT03619122 - Second Forward View Examination of Proximal Colon on Adenoma Detection Rate N/A
Completed NCT03742232 - Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. Phase 4
Completed NCT03336359 - Linked Color Imaging Versus Narrow Band Imaging for Colorectal Adenoma Detection N/A
Recruiting NCT01952418 - Effect of Video Monitor Size on Adenoma Detection Rate N/A
Recruiting NCT01719198 - Usefulness of Calprotectin for Colon Adenoma Screening N/A
Completed NCT03444090 - Impacts of Inspection During Instrument Insertion on Colonoscopy Quality N/A
Completed NCT03690297 - Linked Color Imaging (LCI) for Colorectal Adenoma Detection N/A
Completed NCT03696992 - BLI, NBI or White Light Colonoscopy for Proximal Colonic Adenoma N/A
Not yet recruiting NCT03679429 - NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum
Completed NCT02819492 - Side Specific Withdrawal Times for Colonoscopy: Impact on Adenoma Detection in the Proximal and Distal Colon N/A
Recruiting NCT01992406 - Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection N/A
Recruiting NCT04138030 - Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial N/A
Recruiting NCT06063720 - Effective Withdrawal Time and Adenoma Detection Rate
Not yet recruiting NCT05041478 - Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) N/A
Not yet recruiting NCT03933371 - Predictors of Poor Bowel Cleansing and Capsule Endoscopy (CEPREDICT)
Recruiting NCT05448300 - Adenoma Detection Rate in Water and Air Colonoscopy Using Computer-aided System N/A
Completed NCT03501849 - Cold Snare Polypectomy N/A